Faculty

Institution

Unit

Venue

Hemant K. Roy

Franz Ingelfinger Professor

Boston University

Hemant K. Roy is currently serving as a Franz Ingelfinger Professor at Boston University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Hemant K. Roy

Boston University

Franz Ingelfinger Professor

You can click a keyword to filter the displayed items

oncology health sciences gastroenterology colorectal cancer cancer research cancer biology medicine gastrointestinal oncology hepatology pharmacology clinical gastroenterology digestive diseases tumor biology carcinogenesis medicinal research cancer care cancer genetics colon carcinogenesis cancer risk vascular biology dermatology cancer treatment cancer imaging gastrointestinal endoscopy nanotechnology molecular cancer gene expression cancer screening field carcinogenesis cell regulation cancer prevention respiratory medicine surgical oncology cancer genomics pancreatic cancer biomedical imaging polyethylene glycol genitourinary cancers cancer detection nanobiotechnology cancer cells cancer disparities colon cancer oncogenes thoracic oncology optical imaging cancer growth field carcinogenesis detection liver cancer colonic neoplasia mammalian biology cancer management epidemiology of cancer internal medicine tissue imaging oral cancer early event colorectal cancer risk medical genetics benchmark studies duodenal mucosa partial wave spectroscopy plo biology apoptosis nanoscale science electron microscopy blood supply lynch syndrome host factors cell proliferation optical metrology label-free imaging microscopic colitis biliary cancer colonic cells optical markers radiation oncology biomarker urology prostatic disease molecular diagnostics prostate cancer risk stratification

Notable Scholarly Works

Notable Federal Grants

Collaborators

1254 Stromal Antigen 1 as a Modulator of Program Death Ligand-1 Expression: Implications for Colorectal Cancer Immunotherapy. Gastroenterology (2024)

Mart Dela CruzRohit KumarHemant Kumar Roy

colorectal cancergastrointestinal oncologycolorectal cancer immunotherapyclinical gastroenterologygastroenterologycancer immunotherapyimmunologymedicinal researchimmunotherapycancer researchmedicinepharmacologycancer treatmentoncology

Colorectal Cancer Murine Models: Initiation to Metastasis. Cancer Letters (2024)

Ramesh PothurajuImran KhanManeesh JainMichael BouvetMokenge MalafaHemant K. RoySushil KumarSurinder K. Batra

colorectal cancermetastasiscancer researchmedicinehealth sciencesoncologycancer biology

Early Screening of Colorectal Cancer Using Feature Engineering With Artificial Intelligence-Enhanced Analysis of Nanoscale Chromatin Modifications. Scientific Reports (2024)

Andrew ChangSravya PrabhalaAli DaneshkhahJianan LinHariharan SubramanianHemant Kumar RoyVadim Backman

public healthcolorectal cancerscientific communicationearly diagnosisbioinformaticscancer screeningnanotechnologyscientific computingfeature engineeringearly screeningcancer researchcancer detectionnanoscale chromatin modificationsscientific dataartificial intelligence-enhanced analysishealth sciencesoncologygenetics

O52 Rectal Microrna as a Screening Test for Colon Neoplasia: A Pilot Study. Oral Presentations (2024)

Hemant RoyPriya RoyMart Dela CruzAndrew ChangDhwani Mulani

screening testoral healthcancer screeningoral medicinecolon neoplasiaoral biologypilot studyhealth sciencesoncology

S293 Trends in the Incidence of Early-Onset Colorectal Cancer in Texas From 2000–2019. The American Journal of Gastroenterology (2024)

Adegboyega OlayodeOmar RosalesElyse BurgessAaron ThriftHashem El-SeragHemant RoyAbiodun Oluyomi

public healthcolorectal cancerepidemiologygastroenterologyepidemiology of cancerearly-onset colorectal cancer

Spectroscopy. Oxford University Press eBooks (2024)

Abraham Nitzan

Su1128 Study of Heme-Oxygenase: Its Role in Colon Carcinogenesis as a Potential Prognostic Biomarker. Gastroenterology (2024)

Jake JacobMart Dela CruzPriya RoyHemant Kumar Roy

colorectal cancerprognostic biomarkersprognosisgastroenterologyhepatologydigestive diseasesbiochemistrycarcinogenesiscancer researchcancer riskmolecular biologycolon carcinogenesishealth sciencesoncologycancer biology

Su1133 Rectal Mucosal Gene Expression as a Risk Stratification Tool for Advanced Adenomas: A Pilot Study. Gastroenterology (2024)

Jake JacobAaron P. ThriftMart Dela CruzRohit KumarPriya RoyDhwani MulaniHemant Kumar Roy

gastrointestinal oncologygastroenterologyrisk stratification toolgenitourinary cancersradiologyadvanced adenomasmedicinepilot studyhealth sciencesoncology

Su1158 Chronic Arsenic Exposure Induces Thymidylate Synthase (Tyms) in Colorectal Cancer (Crc) Cells: Implications for 5-Fluorouracil Chemoresistance. Gastroenterology (2024)

Sage ParkerHemant Kumar RoyMart Angelo Dela CruzDhwani MulaniRohit KumarPriya Roy

antioxidantstoxicologyclinical microbiologycolorectal canceranti-cancer agentsclinical gastroenterologygastroenterologymetal toxicityhepatologydigestive diseasescancer researchpharmacologymedicineregulatory toxicologycell regulationenzyme inhibitionhealth sciencesoncology

Tu1946 Glucagon-Like Peptide 1 (Glp-1) Agonists Semaglutide and Tirzepatide and Colorectal Cancer Risk: A Cell Culture Study. Gastroenterology (2024)

Priya RoySage ParkerBeth ParkerMart Dela CruzRohit KumarHemant Kumar Roy

colorectal cancercell culture studyclinical gastroenterologygastroenterologyhepatologycolorectal cancer riskmedicinepharmacologyhealth sciences

1
2
3
4
5
42
10 / page

Hemant K. Roy

Franz Ingelfinger Professor

Boston University

Hemant K. Roy is currently serving as a Franz Ingelfinger Professor at Boston University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Hemant K. Roy

Boston University

Franz Ingelfinger Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

1254 Stromal Antigen 1 as a Modulator of Program Death Ligand-1 Expression: Implications for Colorectal Cancer Immunotherapy. Gastroenterology (2024)

Mart Dela CruzRohit KumarHemant Kumar Roy

Colorectal Cancer Murine Models: Initiation to Metastasis. Cancer Letters (2024)

Ramesh PothurajuImran KhanManeesh JainMichael BouvetMokenge MalafaHemant K. RoySushil KumarSurinder K. Batra

colorectal cancermetastasiscancer researchmedicinehealth sciencesoncologycancer biology

Early Screening of Colorectal Cancer Using Feature Engineering With Artificial Intelligence-Enhanced Analysis of Nanoscale Chromatin Modifications. Scientific Reports (2024)

Andrew ChangSravya PrabhalaAli DaneshkhahJianan LinHariharan SubramanianHemant Kumar RoyVadim Backman

O52 Rectal Microrna as a Screening Test for Colon Neoplasia: A Pilot Study. Oral Presentations (2024)

Hemant RoyPriya RoyMart Dela CruzAndrew ChangDhwani Mulani

screening testoral healthcancer screeningoral medicinecolon neoplasiaoral biologypilot studyhealth sciencesoncology

S293 Trends in the Incidence of Early-Onset Colorectal Cancer in Texas From 2000–2019. The American Journal of Gastroenterology (2024)

Adegboyega OlayodeOmar RosalesElyse BurgessAaron ThriftHashem El-SeragHemant RoyAbiodun Oluyomi

public healthcolorectal cancerepidemiologygastroenterologyepidemiology of cancerearly-onset colorectal cancer

Spectroscopy. Oxford University Press eBooks (2024)

Abraham Nitzan

Su1128 Study of Heme-Oxygenase: Its Role in Colon Carcinogenesis as a Potential Prognostic Biomarker. Gastroenterology (2024)

Jake JacobMart Dela CruzPriya RoyHemant Kumar Roy

Su1133 Rectal Mucosal Gene Expression as a Risk Stratification Tool for Advanced Adenomas: A Pilot Study. Gastroenterology (2024)

Jake JacobAaron P. ThriftMart Dela CruzRohit KumarPriya RoyDhwani MulaniHemant Kumar Roy

gastrointestinal oncologygastroenterologyrisk stratification toolgenitourinary cancersradiologyadvanced adenomasmedicinepilot studyhealth sciencesoncology

Su1158 Chronic Arsenic Exposure Induces Thymidylate Synthase (Tyms) in Colorectal Cancer (Crc) Cells: Implications for 5-Fluorouracil Chemoresistance. Gastroenterology (2024)

Sage ParkerHemant Kumar RoyMart Angelo Dela CruzDhwani MulaniRohit KumarPriya Roy

Tu1946 Glucagon-Like Peptide 1 (Glp-1) Agonists Semaglutide and Tirzepatide and Colorectal Cancer Risk: A Cell Culture Study. Gastroenterology (2024)

Priya RoySage ParkerBeth ParkerMart Dela CruzRohit KumarHemant Kumar Roy

colorectal cancercell culture studyclinical gastroenterologygastroenterologyhepatologycolorectal cancer riskmedicinepharmacologyhealth sciences

1
2
3
4
5
42
10 / page

Similar Faculty Members

John Carethers

Institution

University of California, San Diego

cancer letter

gastroenterology

Vadim Backman

Institution

Northwestern University

oncology

biophysics

Kazuaki Takabe

Institution

University at Buffalo

hepatology

pathology

Stephen D. Hursting

Institution

University of North Carolina at Chapel Hill

health science

energy balance

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Shantu Amin

Institution

Pennsylvania State University

cancer letter

polycyclic aromatic hydrocarbon

Robert Anders

Institution

Johns Hopkins University

oncology

cancer research

Steven K Clinton

Institution

Ohio State University

health sciences

oncology

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Peter Kuhn

Institution

University of Southern California

cancer letter

pathology

Similar Faculty Members

John Carethers

Institution

University of California, San Diego

cancer letter

gastroenterology

Vadim Backman

Institution

Northwestern University

oncology

biophysics

Kazuaki Takabe

Institution

University at Buffalo

hepatology

pathology

Stephen D. Hursting

Institution

University of North Carolina at Chapel Hill

health science

energy balance

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Shantu Amin

Institution

Pennsylvania State University

cancer letter

polycyclic aromatic hydrocarbon

Robert Anders

Institution

Johns Hopkins University

oncology

cancer research

Steven K Clinton

Institution

Ohio State University

health sciences

oncology

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Peter Kuhn

Institution

University of Southern California

cancer letter

pathology